| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1832086 | F | Anticancer activity against human OVCAR8 cells after 96 hrs by SRB assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 2. | ALA1832087 | F | Anticancer activity against mouse B16-F1 cells after 96 hrs by SRB assay | Mus musculus | 44 | cell-based format | Scientific Literature | ||
| 3. | ALA1832088 | F | Anticancer activity against human A375 cells after 96 hrs by SRB assay | Homo sapiens | 44 | cell-based format | Scientific Literature | ||
| 4. | ALA1832089 | F | Anticancer activity against human DU145 cells after 96 hrs by SRB assay | Homo sapiens | 44 | cell-based format | Scientific Literature | ||
| 5. | ALA1832090 | F | Anticancer activity against human PC3 cells after 96 hrs by SRB assay | Homo sapiens | 44 | cell-based format | Scientific Literature | ||
| 6. | ALA1832179 | F | Anticancer activity against human LNCAP cells after 96 hrs by SRB assay | Homo sapiens | 44 | cell-based format | Scientific Literature | ||
| 7. | ALA1832180 | F | Anticancer activity against human PPC1 cells after 96 hrs by SRB assay | Homo sapiens | 44 | cell-based format | Scientific Literature | ||
| 8. | ALA1832182 | F | Anticancer activity against P-gp overexpressing human NCI/ADR-RES cells after 96 hrs by SRB assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 9. | ALA1832184 | A | Systemic clearance in Sprague-Dawley rat at 2.5 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA1832185 | A | Volume of distribution at steady state in Sprague-Dawley rat at 2.5 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA1832186 | A | AUC in Sprague-Dawley rat at 2.5 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA1832187 | A | Cmax in Sprague-Dawley rat at 2.5 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 13. | ALA1832191 | A | AUC in Sprague-Dawley rat at 4 mg/kg, po by LC-MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA1832192 | A | Cmax in Sprague-Dawley rat at 4 mg/kg, po by LC-MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA1832198 | P | Aqueous solubility of the compound in PBS at 35 ug/ml and pH 7.4 by LC/MS/MS analysis | 1 | small-molecule physicochemical format | Scientific Literature | |||
| 16. | ALA1832358 | F | Resistance factor, ratio of IC50 for human NCI-ADR-RES cells to IC50 for drug-sensitive human OVCAR8 cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 17. | ALA1832360 | A | Oral bioavailability in Sprague-Dawley rat at 4 mg/kg by LC-MS/MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!